nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Leflunomide—rheumatoid arthritis	0.0598	0.0826	CbGbCtD
Buprenorphine—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0369	0.0511	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—rheumatoid arthritis	0.0338	0.0467	CbGbCtD
Buprenorphine—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0296	0.041	CbGbCtD
Buprenorphine—ABCG2—Cyclosporine—rheumatoid arthritis	0.028	0.0387	CbGbCtD
Buprenorphine—CYP1A2—Leflunomide—rheumatoid arthritis	0.0246	0.0341	CbGbCtD
Buprenorphine—CYP2C9—Leflunomide—rheumatoid arthritis	0.0222	0.0307	CbGbCtD
Buprenorphine—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.0219	0.0303	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.0219	0.0303	CbGbCtD
Buprenorphine—CYP3A7—Cyclosporine—rheumatoid arthritis	0.0207	0.0286	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.0207	0.0286	CbGbCtD
Buprenorphine—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0205	0.0283	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—rheumatoid arthritis	0.0199	0.0275	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—rheumatoid arthritis	0.0184	0.0255	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0176	0.0243	CbGbCtD
Buprenorphine—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0164	0.0227	CbGbCtD
Buprenorphine—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0158	0.0218	CbGbCtD
Buprenorphine—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0155	0.0214	CbGbCtD
Buprenorphine—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0149	0.0206	CbGbCtD
Buprenorphine—ABCG2—Methotrexate—rheumatoid arthritis	0.0148	0.0205	CbGbCtD
Buprenorphine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0143	0.0197	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.0136	0.0188	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—rheumatoid arthritis	0.0136	0.0188	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—rheumatoid arthritis	0.0132	0.0182	CbGbCtD
Buprenorphine—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0125	0.0173	CbGbCtD
Buprenorphine—ABCB1—Betamethasone—rheumatoid arthritis	0.0114	0.0158	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—rheumatoid arthritis	0.0113	0.0156	CbGbCtD
Buprenorphine—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0107	0.0148	CbGbCtD
Buprenorphine—ABCB1—Prednisone—rheumatoid arthritis	0.0106	0.0147	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0105	0.0146	CbGbCtD
Buprenorphine—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0104	0.0144	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0102	0.0141	CbGbCtD
Buprenorphine—ABCB1—Cyclosporine—rheumatoid arthritis	0.0101	0.014	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—rheumatoid arthritis	0.00982	0.0136	CbGbCtD
Buprenorphine—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00951	0.0131	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00823	0.0114	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00798	0.011	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00685	0.00947	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—rheumatoid arthritis	0.00684	0.00946	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—rheumatoid arthritis	0.00675	0.00934	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—rheumatoid arthritis	0.00664	0.00919	CbGbCtD
Buprenorphine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0064	0.00885	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—rheumatoid arthritis	0.00638	0.00882	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00626	0.00866	CbGbCtD
Buprenorphine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00605	0.00836	CbGbCtD
Buprenorphine—ABCB1—Methotrexate—rheumatoid arthritis	0.00534	0.00738	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00398	0.00551	CbGbCtD
Buprenorphine—Naloxone—TLR4—rheumatoid arthritis	0.00243	0.889	CrCbGaD
Buprenorphine—Naloxone—ALB—rheumatoid arthritis	0.000303	0.111	CrCbGaD
Buprenorphine—Anxiety—Betamethasone—rheumatoid arthritis	0.000117	0.000621	CcSEcCtD
Buprenorphine—Discomfort—Dexamethasone—rheumatoid arthritis	0.000116	0.000615	CcSEcCtD
Buprenorphine—Discomfort—Betamethasone—rheumatoid arthritis	0.000116	0.000615	CcSEcCtD
Buprenorphine—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000116	0.000615	CcSEcCtD
Buprenorphine—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000115	0.000614	CcSEcCtD
Buprenorphine—Pain—Prednisolone—rheumatoid arthritis	0.000115	0.000612	CcSEcCtD
Buprenorphine—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000114	0.000608	CcSEcCtD
Buprenorphine—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000114	0.000607	CcSEcCtD
Buprenorphine—Nausea—Leflunomide—rheumatoid arthritis	0.000114	0.000605	CcSEcCtD
Buprenorphine—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000114	0.000604	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000114	0.000603	CcSEcCtD
Buprenorphine—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000113	0.000603	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—rheumatoid arthritis	0.000113	0.0006	CcSEcCtD
Buprenorphine—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000113	0.0006	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000113	0.0006	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000113	0.000598	CcSEcCtD
Buprenorphine—Pain—Hydrocortisone—rheumatoid arthritis	0.000112	0.000598	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000112	0.000597	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—rheumatoid arthritis	0.000112	0.000597	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—rheumatoid arthritis	0.000112	0.000597	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000112	0.000597	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—rheumatoid arthritis	0.000112	0.000595	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000112	0.000594	CcSEcCtD
Buprenorphine—Infection—Betamethasone—rheumatoid arthritis	0.000112	0.000593	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—rheumatoid arthritis	0.000112	0.000593	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000111	0.000591	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000111	0.000591	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000111	0.00059	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000111	0.00059	CcSEcCtD
Buprenorphine—Visual impairment—Methotrexate—rheumatoid arthritis	0.000111	0.000589	CcSEcCtD
Buprenorphine—Shock—Betamethasone—rheumatoid arthritis	0.000111	0.000587	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—rheumatoid arthritis	0.000111	0.000587	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.00011	0.000587	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00011	0.000586	CcSEcCtD
Buprenorphine—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00011	0.000586	CcSEcCtD
Buprenorphine—Agitation—Prednisone—rheumatoid arthritis	0.00011	0.000585	CcSEcCtD
Buprenorphine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.00011	0.000583	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—rheumatoid arthritis	0.00011	0.000583	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—rheumatoid arthritis	0.00011	0.000582	CcSEcCtD
Buprenorphine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000109	0.000579	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000109	0.000579	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000109	0.000578	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000109	0.000577	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000109	0.000577	CcSEcCtD
Buprenorphine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000108	0.000576	CcSEcCtD
Buprenorphine—Malaise—Prednisone—rheumatoid arthritis	0.000108	0.000575	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—rheumatoid arthritis	0.000108	0.000572	CcSEcCtD
Buprenorphine—Eye disorder—Methotrexate—rheumatoid arthritis	0.000108	0.000572	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000108	0.000571	CcSEcCtD
Buprenorphine—Syncope—Prednisone—rheumatoid arthritis	0.000107	0.000571	CcSEcCtD
Buprenorphine—Tinnitus—Methotrexate—rheumatoid arthritis	0.000107	0.00057	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—rheumatoid arthritis	0.000107	0.000569	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—rheumatoid arthritis	0.000107	0.000569	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—rheumatoid arthritis	0.000107	0.000568	CcSEcCtD
Buprenorphine—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000107	0.000568	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—rheumatoid arthritis	0.000107	0.000567	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000107	0.000566	CcSEcCtD
Buprenorphine—Asthenia—Cyclosporine—rheumatoid arthritis	0.000106	0.000564	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—rheumatoid arthritis	0.000106	0.000563	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000105	0.00056	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—rheumatoid arthritis	0.000105	0.000558	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—rheumatoid arthritis	0.000105	0.000558	CcSEcCtD
Buprenorphine—Pruritus—Cyclosporine—rheumatoid arthritis	0.000105	0.000556	CcSEcCtD
Buprenorphine—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000104	0.000555	CcSEcCtD
Buprenorphine—Angiopathy—Methotrexate—rheumatoid arthritis	0.000104	0.000555	CcSEcCtD
Buprenorphine—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000104	0.000552	CcSEcCtD
Buprenorphine—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000104	0.000552	CcSEcCtD
Buprenorphine—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000104	0.000552	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—rheumatoid arthritis	0.000104	0.000552	CcSEcCtD
Buprenorphine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000104	0.000551	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—rheumatoid arthritis	0.000103	0.00055	CcSEcCtD
Buprenorphine—Chills—Methotrexate—rheumatoid arthritis	0.000103	0.000549	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000102	0.000544	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000102	0.000544	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—rheumatoid arthritis	0.000102	0.000542	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—rheumatoid arthritis	0.000102	0.000542	CcSEcCtD
Buprenorphine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000102	0.000542	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000102	0.000541	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—rheumatoid arthritis	0.000102	0.000541	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—rheumatoid arthritis	0.000102	0.00054	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—rheumatoid arthritis	0.000102	0.00054	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000101	0.000539	CcSEcCtD
Buprenorphine—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000101	0.000538	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000101	0.000537	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000101	0.000536	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000101	0.000536	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—rheumatoid arthritis	0.000101	0.000536	CcSEcCtD
Buprenorphine—Mental disorder—Methotrexate—rheumatoid arthritis	0.000101	0.000536	CcSEcCtD
Buprenorphine—Erythema—Methotrexate—rheumatoid arthritis	0.0001	0.000532	CcSEcCtD
Buprenorphine—Malnutrition—Methotrexate—rheumatoid arthritis	0.0001	0.000532	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—rheumatoid arthritis	9.92e-05	0.000527	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—rheumatoid arthritis	9.89e-05	0.000526	CcSEcCtD
Buprenorphine—Dyspepsia—Dexamethasone—rheumatoid arthritis	9.89e-05	0.000526	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—rheumatoid arthritis	9.84e-05	0.000523	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—rheumatoid arthritis	9.81e-05	0.000522	CcSEcCtD
Buprenorphine—Dysgeusia—Methotrexate—rheumatoid arthritis	9.81e-05	0.000521	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—rheumatoid arthritis	9.79e-05	0.00052	CcSEcCtD
Buprenorphine—Dizziness—Cyclosporine—rheumatoid arthritis	9.78e-05	0.00052	CcSEcCtD
Buprenorphine—Oedema—Prednisone—rheumatoid arthritis	9.78e-05	0.00052	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—rheumatoid arthritis	9.78e-05	0.00052	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—rheumatoid arthritis	9.77e-05	0.000519	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—rheumatoid arthritis	9.77e-05	0.000519	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—rheumatoid arthritis	9.77e-05	0.000519	CcSEcCtD
Buprenorphine—Infection—Prednisone—rheumatoid arthritis	9.72e-05	0.000517	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	9.7e-05	0.000515	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	9.7e-05	0.000515	CcSEcCtD
Buprenorphine—Back pain—Methotrexate—rheumatoid arthritis	9.69e-05	0.000515	CcSEcCtD
Buprenorphine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	9.69e-05	0.000515	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—rheumatoid arthritis	9.69e-05	0.000515	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—rheumatoid arthritis	9.69e-05	0.000515	CcSEcCtD
Buprenorphine—Shock—Prednisone—rheumatoid arthritis	9.62e-05	0.000512	CcSEcCtD
Buprenorphine—Pain—Betamethasone—rheumatoid arthritis	9.61e-05	0.000511	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—rheumatoid arthritis	9.61e-05	0.000511	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—rheumatoid arthritis	9.59e-05	0.00051	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—rheumatoid arthritis	9.55e-05	0.000507	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—rheumatoid arthritis	9.5e-05	0.000505	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—rheumatoid arthritis	9.46e-05	0.000503	CcSEcCtD
Buprenorphine—Vision blurred—Methotrexate—rheumatoid arthritis	9.44e-05	0.000502	CcSEcCtD
Buprenorphine—Asthenia—Hydrocortisone—rheumatoid arthritis	9.43e-05	0.000501	CcSEcCtD
Buprenorphine—Vomiting—Cyclosporine—rheumatoid arthritis	9.41e-05	0.0005	CcSEcCtD
Buprenorphine—Rash—Cyclosporine—rheumatoid arthritis	9.33e-05	0.000496	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—rheumatoid arthritis	9.33e-05	0.000496	CcSEcCtD
Buprenorphine—Dermatitis—Cyclosporine—rheumatoid arthritis	9.32e-05	0.000495	CcSEcCtD
Buprenorphine—Pruritus—Hydrocortisone—rheumatoid arthritis	9.3e-05	0.000494	CcSEcCtD
Buprenorphine—Ill-defined disorder—Methotrexate—rheumatoid arthritis	9.3e-05	0.000494	CcSEcCtD
Buprenorphine—Headache—Cyclosporine—rheumatoid arthritis	9.27e-05	0.000493	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—rheumatoid arthritis	9.26e-05	0.000492	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	9.26e-05	0.000492	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	9.19e-05	0.000488	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	9.19e-05	0.000488	CcSEcCtD
Buprenorphine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	9.12e-05	0.000485	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	9.1e-05	0.000484	CcSEcCtD
Buprenorphine—Malaise—Methotrexate—rheumatoid arthritis	9.03e-05	0.00048	CcSEcCtD
Buprenorphine—Vertigo—Methotrexate—rheumatoid arthritis	9e-05	0.000478	CcSEcCtD
Buprenorphine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	9e-05	0.000478	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—rheumatoid arthritis	8.92e-05	0.000474	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—rheumatoid arthritis	8.92e-05	0.000474	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	8.91e-05	0.000474	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—rheumatoid arthritis	8.9e-05	0.000473	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—rheumatoid arthritis	8.88e-05	0.000472	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—rheumatoid arthritis	8.88e-05	0.000472	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—rheumatoid arthritis	8.88e-05	0.000472	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—rheumatoid arthritis	8.88e-05	0.000472	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—rheumatoid arthritis	8.88e-05	0.000472	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—rheumatoid arthritis	8.86e-05	0.000471	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—rheumatoid arthritis	8.85e-05	0.00047	CcSEcCtD
Buprenorphine—Nausea—Cyclosporine—rheumatoid arthritis	8.79e-05	0.000467	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—rheumatoid arthritis	8.78e-05	0.000467	CcSEcCtD
Buprenorphine—Pruritus—Triamcinolone—rheumatoid arthritis	8.76e-05	0.000466	CcSEcCtD
Buprenorphine—Cough—Methotrexate—rheumatoid arthritis	8.74e-05	0.000465	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—rheumatoid arthritis	8.74e-05	0.000465	CcSEcCtD
Buprenorphine—Dizziness—Hydrocortisone—rheumatoid arthritis	8.69e-05	0.000462	CcSEcCtD
Buprenorphine—Convulsion—Methotrexate—rheumatoid arthritis	8.68e-05	0.000461	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—rheumatoid arthritis	8.61e-05	0.000458	CcSEcCtD
Buprenorphine—Myalgia—Methotrexate—rheumatoid arthritis	8.53e-05	0.000453	CcSEcCtD
Buprenorphine—Arthralgia—Methotrexate—rheumatoid arthritis	8.53e-05	0.000453	CcSEcCtD
Buprenorphine—Chest pain—Methotrexate—rheumatoid arthritis	8.53e-05	0.000453	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—rheumatoid arthritis	8.5e-05	0.000452	CcSEcCtD
Buprenorphine—Rash—Prednisolone—rheumatoid arthritis	8.49e-05	0.000451	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—rheumatoid arthritis	8.48e-05	0.000451	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	8.47e-05	0.00045	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	8.45e-05	0.000449	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—rheumatoid arthritis	8.43e-05	0.000448	CcSEcCtD
Buprenorphine—Headache—Prednisolone—rheumatoid arthritis	8.43e-05	0.000448	CcSEcCtD
Buprenorphine—Discomfort—Methotrexate—rheumatoid arthritis	8.43e-05	0.000448	CcSEcCtD
Buprenorphine—Constipation—Prednisone—rheumatoid arthritis	8.37e-05	0.000445	CcSEcCtD
Buprenorphine—Vomiting—Hydrocortisone—rheumatoid arthritis	8.36e-05	0.000444	CcSEcCtD
Buprenorphine—Rash—Hydrocortisone—rheumatoid arthritis	8.29e-05	0.000441	CcSEcCtD
Buprenorphine—Dermatitis—Hydrocortisone—rheumatoid arthritis	8.28e-05	0.00044	CcSEcCtD
Buprenorphine—Confusional state—Methotrexate—rheumatoid arthritis	8.24e-05	0.000438	CcSEcCtD
Buprenorphine—Headache—Hydrocortisone—rheumatoid arthritis	8.24e-05	0.000438	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—rheumatoid arthritis	8.19e-05	0.000435	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methotrexate—rheumatoid arthritis	8.18e-05	0.000435	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—rheumatoid arthritis	8.17e-05	0.000434	CcSEcCtD
Buprenorphine—Infection—Methotrexate—rheumatoid arthritis	8.12e-05	0.000432	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—rheumatoid arthritis	8.06e-05	0.000428	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—rheumatoid arthritis	8.06e-05	0.000428	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—rheumatoid arthritis	8.06e-05	0.000428	CcSEcCtD
Buprenorphine—Nervous system disorder—Methotrexate—rheumatoid arthritis	8.02e-05	0.000426	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—rheumatoid arthritis	8e-05	0.000425	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—rheumatoid arthritis	8e-05	0.000425	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—rheumatoid arthritis	7.95e-05	0.000422	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—rheumatoid arthritis	7.95e-05	0.000422	CcSEcCtD
Buprenorphine—Skin disorder—Methotrexate—rheumatoid arthritis	7.94e-05	0.000422	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	7.9e-05	0.00042	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—rheumatoid arthritis	7.87e-05	0.000418	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—rheumatoid arthritis	7.85e-05	0.000417	CcSEcCtD
Buprenorphine—Nausea—Hydrocortisone—rheumatoid arthritis	7.81e-05	0.000415	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—rheumatoid arthritis	7.81e-05	0.000415	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—rheumatoid arthritis	7.8e-05	0.000415	CcSEcCtD
Buprenorphine—Anorexia—Methotrexate—rheumatoid arthritis	7.79e-05	0.000414	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—rheumatoid arthritis	7.79e-05	0.000414	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—rheumatoid arthritis	7.78e-05	0.000414	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—rheumatoid arthritis	7.77e-05	0.000413	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—rheumatoid arthritis	7.76e-05	0.000412	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—rheumatoid arthritis	7.74e-05	0.000411	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—rheumatoid arthritis	7.73e-05	0.000411	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—rheumatoid arthritis	7.73e-05	0.000411	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—rheumatoid arthritis	7.69e-05	0.000409	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—rheumatoid arthritis	7.69e-05	0.000409	CcSEcCtD
Buprenorphine—Hypotension—Methotrexate—rheumatoid arthritis	7.64e-05	0.000406	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	7.45e-05	0.000396	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—rheumatoid arthritis	7.43e-05	0.000395	CcSEcCtD
Buprenorphine—Dizziness—Dexamethasone—rheumatoid arthritis	7.43e-05	0.000395	CcSEcCtD
Buprenorphine—Insomnia—Methotrexate—rheumatoid arthritis	7.39e-05	0.000393	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—rheumatoid arthritis	7.35e-05	0.000391	CcSEcCtD
Buprenorphine—Paraesthesia—Methotrexate—rheumatoid arthritis	7.34e-05	0.00039	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—rheumatoid arthritis	7.34e-05	0.00039	CcSEcCtD
Buprenorphine—Dyspnoea—Methotrexate—rheumatoid arthritis	7.29e-05	0.000387	CcSEcCtD
Buprenorphine—Somnolence—Methotrexate—rheumatoid arthritis	7.27e-05	0.000386	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—rheumatoid arthritis	7.21e-05	0.000383	CcSEcCtD
Buprenorphine—Dyspepsia—Methotrexate—rheumatoid arthritis	7.2e-05	0.000383	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—rheumatoid arthritis	7.14e-05	0.00038	CcSEcCtD
Buprenorphine—Vomiting—Betamethasone—rheumatoid arthritis	7.14e-05	0.00038	CcSEcCtD
Buprenorphine—Decreased appetite—Methotrexate—rheumatoid arthritis	7.11e-05	0.000378	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—rheumatoid arthritis	7.08e-05	0.000376	CcSEcCtD
Buprenorphine—Rash—Betamethasone—rheumatoid arthritis	7.08e-05	0.000376	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—rheumatoid arthritis	7.08e-05	0.000376	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—rheumatoid arthritis	7.08e-05	0.000376	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.06e-05	0.000375	CcSEcCtD
Buprenorphine—Fatigue—Methotrexate—rheumatoid arthritis	7.05e-05	0.000375	CcSEcCtD
Buprenorphine—Headache—Betamethasone—rheumatoid arthritis	7.04e-05	0.000374	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—rheumatoid arthritis	7.04e-05	0.000374	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—rheumatoid arthritis	7.02e-05	0.000373	CcSEcCtD
Buprenorphine—Pain—Methotrexate—rheumatoid arthritis	6.99e-05	0.000372	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—rheumatoid arthritis	6.92e-05	0.000368	CcSEcCtD
Buprenorphine—Feeling abnormal—Methotrexate—rheumatoid arthritis	6.74e-05	0.000358	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—rheumatoid arthritis	6.69e-05	0.000356	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	6.69e-05	0.000355	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—rheumatoid arthritis	6.67e-05	0.000355	CcSEcCtD
Buprenorphine—Nausea—Dexamethasone—rheumatoid arthritis	6.67e-05	0.000355	CcSEcCtD
Buprenorphine—Urticaria—Methotrexate—rheumatoid arthritis	6.5e-05	0.000345	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—rheumatoid arthritis	6.47e-05	0.000344	CcSEcCtD
Buprenorphine—Abdominal pain—Methotrexate—rheumatoid arthritis	6.46e-05	0.000344	CcSEcCtD
Buprenorphine—Body temperature increased—Methotrexate—rheumatoid arthritis	6.46e-05	0.000344	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—rheumatoid arthritis	6.22e-05	0.000331	CcSEcCtD
Buprenorphine—Rash—Prednisone—rheumatoid arthritis	6.17e-05	0.000328	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—rheumatoid arthritis	6.16e-05	0.000328	CcSEcCtD
Buprenorphine—Headache—Prednisone—rheumatoid arthritis	6.13e-05	0.000326	CcSEcCtD
Buprenorphine—Hypersensitivity—Methotrexate—rheumatoid arthritis	6.02e-05	0.00032	CcSEcCtD
Buprenorphine—Asthenia—Methotrexate—rheumatoid arthritis	5.87e-05	0.000312	CcSEcCtD
Buprenorphine—Nausea—Prednisone—rheumatoid arthritis	5.81e-05	0.000309	CcSEcCtD
Buprenorphine—Pruritus—Methotrexate—rheumatoid arthritis	5.78e-05	0.000307	CcSEcCtD
Buprenorphine—Diarrhoea—Methotrexate—rheumatoid arthritis	5.59e-05	0.000297	CcSEcCtD
Buprenorphine—Dizziness—Methotrexate—rheumatoid arthritis	5.41e-05	0.000287	CcSEcCtD
Buprenorphine—Vomiting—Methotrexate—rheumatoid arthritis	5.2e-05	0.000276	CcSEcCtD
Buprenorphine—Rash—Methotrexate—rheumatoid arthritis	5.16e-05	0.000274	CcSEcCtD
Buprenorphine—Dermatitis—Methotrexate—rheumatoid arthritis	5.15e-05	0.000274	CcSEcCtD
Buprenorphine—Headache—Methotrexate—rheumatoid arthritis	5.12e-05	0.000272	CcSEcCtD
Buprenorphine—Nausea—Methotrexate—rheumatoid arthritis	4.86e-05	0.000258	CcSEcCtD
Buprenorphine—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	1.3e-05	0.000151	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.29e-05	0.000151	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CSF2—rheumatoid arthritis	1.29e-05	0.00015	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	1.28e-05	0.000149	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL12—rheumatoid arthritis	1.28e-05	0.000148	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.28e-05	0.000148	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—POMC—rheumatoid arthritis	1.27e-05	0.000148	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.27e-05	0.000148	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MED1—rheumatoid arthritis	1.27e-05	0.000148	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6ST—rheumatoid arthritis	1.26e-05	0.000147	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.26e-05	0.000147	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CAT—rheumatoid arthritis	1.25e-05	0.000146	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.25e-05	0.000145	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GC—rheumatoid arthritis	1.24e-05	0.000145	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	1.24e-05	0.000145	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—BGN—rheumatoid arthritis	1.22e-05	0.000142	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP3—rheumatoid arthritis	1.22e-05	0.000141	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TYK2—rheumatoid arthritis	1.22e-05	0.000141	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SPP1—rheumatoid arthritis	1.21e-05	0.000141	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	1.21e-05	0.000141	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	1.21e-05	0.000141	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.21e-05	0.00014	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MED1—rheumatoid arthritis	1.2e-05	0.000139	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.19e-05	0.000138	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.19e-05	0.000138	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MED1—rheumatoid arthritis	1.19e-05	0.000138	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SYK—rheumatoid arthritis	1.19e-05	0.000138	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	1.18e-05	0.000137	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ACP5—rheumatoid arthritis	1.18e-05	0.000137	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR5—rheumatoid arthritis	1.18e-05	0.000137	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTK2—rheumatoid arthritis	1.17e-05	0.000136	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.17e-05	0.000136	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.16e-05	0.000135	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.16e-05	0.000135	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	1.16e-05	0.000134	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—POMC—rheumatoid arthritis	1.16e-05	0.000134	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2—rheumatoid arthritis	1.15e-05	0.000134	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—C3—rheumatoid arthritis	1.15e-05	0.000134	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL5—rheumatoid arthritis	1.15e-05	0.000133	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STAT1—rheumatoid arthritis	1.14e-05	0.000133	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	1.13e-05	0.000132	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CSF2—rheumatoid arthritis	1.13e-05	0.000131	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	1.13e-05	0.000131	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	1.13e-05	0.000131	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALOX5—rheumatoid arthritis	1.12e-05	0.000131	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.11e-05	0.000129	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	1.11e-05	0.000129	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	1.11e-05	0.000129	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.11e-05	0.000129	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	1.1e-05	0.000128	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	1.1e-05	0.000128	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—BGN—rheumatoid arthritis	1.09e-05	0.000127	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.09e-05	0.000126	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LEP—rheumatoid arthritis	1.07e-05	0.000125	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—BGN—rheumatoid arthritis	1.06e-05	0.000124	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SPP1—rheumatoid arthritis	1.06e-05	0.000124	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CAT—rheumatoid arthritis	1.06e-05	0.000123	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.06e-05	0.000123	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	1.06e-05	0.000123	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—POMC—rheumatoid arthritis	1.06e-05	0.000123	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CAT—rheumatoid arthritis	1.05e-05	0.000122	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.05e-05	0.000122	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MTHFR—rheumatoid arthritis	1.04e-05	0.000121	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR5—rheumatoid arthritis	1.03e-05	0.00012	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP3—rheumatoid arthritis	1.03e-05	0.00012	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	1.03e-05	0.000119	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—rheumatoid arthritis	1.02e-05	0.000119	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.02e-05	0.000118	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MED1—rheumatoid arthritis	1.01e-05	0.000118	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FN1—rheumatoid arthritis	1.01e-05	0.000118	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2—rheumatoid arthritis	1.01e-05	0.000118	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—C3—rheumatoid arthritis	1.01e-05	0.000117	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.01e-05	0.000117	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	1e-05	0.000117	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—BGN—rheumatoid arthritis	1e-05	0.000116	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—BGN—rheumatoid arthritis	9.93e-06	0.000115	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTK2—rheumatoid arthritis	9.89e-06	0.000115	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.88e-06	0.000115	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	9.87e-06	0.000115	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.85e-06	0.000115	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	9.78e-06	0.000114	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	9.78e-06	0.000114	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL5—rheumatoid arthritis	9.7e-06	0.000113	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD80—rheumatoid arthritis	9.7e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CAT—rheumatoid arthritis	9.65e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—rheumatoid arthritis	9.63e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	9.6e-06	0.000112	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GC—rheumatoid arthritis	9.6e-06	0.000112	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CSF2—rheumatoid arthritis	9.55e-06	0.000111	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	9.43e-06	0.00011	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	9.43e-06	0.00011	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	9.41e-06	0.000109	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LEP—rheumatoid arthritis	9.41e-06	0.000109	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—rheumatoid arthritis	9.38e-06	0.000109	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	9.22e-06	0.000107	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—POMC—rheumatoid arthritis	9.22e-06	0.000107	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NOS3—rheumatoid arthritis	9.22e-06	0.000107	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	9.15e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	9.14e-06	0.000106	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCL2—rheumatoid arthritis	9.02e-06	0.000105	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	9e-06	0.000105	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6R—rheumatoid arthritis	8.99e-06	0.000105	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SPP1—rheumatoid arthritis	8.98e-06	0.000104	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.94e-06	0.000104	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	8.92e-06	0.000104	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FN1—rheumatoid arthritis	8.87e-06	0.000103	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	8.86e-06	0.000103	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6ST—rheumatoid arthritis	8.84e-06	0.000103	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.82e-06	0.000103	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—rheumatoid arthritis	8.78e-06	0.000102	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR5—rheumatoid arthritis	8.74e-06	0.000102	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	8.61e-06	0.0001	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2—rheumatoid arthritis	8.55e-06	9.94e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—C3—rheumatoid arthritis	8.54e-06	9.93e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD80—rheumatoid arthritis	8.51e-06	9.89e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—BGN—rheumatoid arthritis	8.49e-06	9.87e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—rheumatoid arthritis	8.43e-06	9.8e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—rheumatoid arthritis	8.35e-06	9.71e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TYK2—rheumatoid arthritis	8.19e-06	9.52e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	8.17e-06	9.5e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—rheumatoid arthritis	8.08e-06	9.4e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—rheumatoid arthritis	8.05e-06	9.36e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.04e-06	9.35e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—rheumatoid arthritis	8.04e-06	9.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.04e-06	9.35e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ENO1—rheumatoid arthritis	7.98e-06	9.27e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—rheumatoid arthritis	7.95e-06	9.24e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL2—rheumatoid arthritis	7.91e-06	9.19e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6R—rheumatoid arthritis	7.88e-06	9.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.88e-06	9.16e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MED1—rheumatoid arthritis	7.82e-06	9.1e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	7.81e-06	9.08e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—rheumatoid arthritis	7.62e-06	8.86e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAT—rheumatoid arthritis	7.61e-06	8.85e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	7.52e-06	8.74e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FN1—rheumatoid arthritis	7.5e-06	8.72e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	7.47e-06	8.68e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.46e-06	8.67e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	7.45e-06	8.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	7.33e-06	8.52e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—rheumatoid arthritis	7.28e-06	8.47e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	7.27e-06	8.46e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	7.27e-06	8.46e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD80—rheumatoid arthritis	7.19e-06	8.36e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TYK2—rheumatoid arthritis	7.18e-06	8.35e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	7.13e-06	8.29e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—rheumatoid arthritis	7.09e-06	8.24e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—rheumatoid arthritis	7.05e-06	8.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.03e-06	8.18e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—rheumatoid arthritis	7.02e-06	8.17e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.87e-06	7.99e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—rheumatoid arthritis	6.83e-06	7.94e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2—rheumatoid arthritis	6.81e-06	7.92e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—rheumatoid arthritis	6.78e-06	7.88e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL2—rheumatoid arthritis	6.68e-06	7.77e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6R—rheumatoid arthritis	6.66e-06	7.75e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—rheumatoid arthritis	6.66e-06	7.75e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAT—rheumatoid arthritis	6.59e-06	7.66e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	6.55e-06	7.62e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—rheumatoid arthritis	6.46e-06	7.51e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—rheumatoid arthritis	6.45e-06	7.5e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—rheumatoid arthritis	6.44e-06	7.49e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	6.41e-06	7.45e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—rheumatoid arthritis	6.4e-06	7.45e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	6.38e-06	7.42e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	6.37e-06	7.4e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	6.35e-06	7.38e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	6.27e-06	7.29e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.26e-06	7.28e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—rheumatoid arthritis	6.25e-06	7.27e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—rheumatoid arthritis	6.18e-06	7.19e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—rheumatoid arthritis	6.13e-06	7.12e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TYK2—rheumatoid arthritis	6.07e-06	7.06e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	6.03e-06	7.01e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2—rheumatoid arthritis	5.97e-06	6.95e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—rheumatoid arthritis	5.96e-06	6.93e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—rheumatoid arthritis	5.94e-06	6.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAT—rheumatoid arthritis	5.88e-06	6.84e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—rheumatoid arthritis	5.87e-06	6.83e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	5.79e-06	6.73e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAT—rheumatoid arthritis	5.74e-06	6.68e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—rheumatoid arthritis	5.65e-06	6.57e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	5.65e-06	6.57e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—rheumatoid arthritis	5.62e-06	6.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—rheumatoid arthritis	5.6e-06	6.52e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	5.59e-06	6.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	5.5e-06	6.39e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	5.5e-06	6.39e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.48e-06	6.37e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	5.41e-06	6.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAT—rheumatoid arthritis	5.36e-06	6.24e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	5.31e-06	6.18e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	5.28e-06	6.14e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—rheumatoid arthritis	5.14e-06	5.97e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—rheumatoid arthritis	5.08e-06	5.9e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	5.08e-06	5.9e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2—rheumatoid arthritis	5.05e-06	5.87e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—rheumatoid arthritis	5.02e-06	5.84e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	4.91e-06	5.71e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	4.91e-06	5.71e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	4.79e-06	5.57e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—rheumatoid arthritis	4.78e-06	5.56e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.73e-06	5.5e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.66e-06	5.42e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	4.65e-06	5.4e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—rheumatoid arthritis	4.63e-06	5.38e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	4.58e-06	5.33e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	4.51e-06	5.25e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	4.48e-06	5.2e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	4.43e-06	5.15e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—rheumatoid arthritis	4.4e-06	5.11e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—rheumatoid arthritis	4.38e-06	5.09e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	4.29e-06	4.99e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	4.05e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—rheumatoid arthritis	4.01e-06	4.66e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—rheumatoid arthritis	4e-06	4.66e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.94e-06	4.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—rheumatoid arthritis	3.93e-06	4.56e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—rheumatoid arthritis	3.84e-06	4.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	3.84e-06	4.46e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—rheumatoid arthritis	3.83e-06	4.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	3.82e-06	4.45e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	3.61e-06	4.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—rheumatoid arthritis	3.58e-06	4.16e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—rheumatoid arthritis	3.58e-06	4.16e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	3.54e-06	4.11e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—rheumatoid arthritis	3.51e-06	4.08e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	3.51e-06	4.08e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.49e-06	4.06e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	3.42e-06	3.98e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—rheumatoid arthritis	3.34e-06	3.89e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	3.29e-06	3.83e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—rheumatoid arthritis	3.26e-06	3.79e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—rheumatoid arthritis	3.24e-06	3.77e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.15e-06	3.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	3.13e-06	3.64e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	3.12e-06	3.63e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	3.06e-06	3.56e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	3.06e-06	3.55e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—rheumatoid arthritis	2.97e-06	3.45e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.95e-06	3.43e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	2.88e-06	3.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	2.86e-06	3.32e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	2.79e-06	3.24e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	2.67e-06	3.1e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.44e-06	2.84e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.36e-06	2.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.15e-06	2.5e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.06e-06	2.39e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.88e-06	2.19e-05	CbGpPWpGaD
